Cardiovascular Diseases Clinical Trial
To conduct a 25-year follow-up of the surviving participants in the Western Collaborative Group Study, the first large prospective study of coronary heart disease risk factors to incorporate direct assessment of Type A behavior.
BACKGROUND:
The WCGS began in 1960 with 3,524 male volunteers who were employed by 11 California
companies. Subjects were 39 to 59 years old and free of heart disease as determined by
electrocardiogram. After the initial screening, the study population dropped to 3,154 and
the number of companies to 10 because of various exclusions. The cohort comprised both blue-
and white-collar employees. At baseline the following information was collected:
socio-demographic including age, education, marital status, income, occupation; physical and
physiological including height, weight, blood pressure, electrocardiogram, and corneal
arcus; biochemical including cholesterol and lipoprotein fractions; medical and family
history and use of medications; behavioral data including Type A interview, smoking,
exercise, and alcohol use. Later surveys added data on anthropometry, triglycerides, Jenkins
Activity Survey, and caffeine use. Average follow-up continued for 8.5 years with repeat
examinations. During the 8.5 year follow-up, coronary heart disease occurred in 257 of the
initially disease-free group, of whom 50 died of coronary heart disease. There were 90
non-coronary disease deaths. Multiple logistic analyses confirmed the roles of blood
pressure, serum cholesterol and cigarette smoking as risk factors. The study also found that
Type A behavior, as assessed by a Structured Interview, was associated independently with
the risk of coronary heart disease and constituted a 2:1 risk.
In 1982, Dr. Richard Brand and Dr. David Ragland at the School of Public Health, University
of California at Berkeley, conducted a Mortality Follow-up of the 3,014 WCGS subjects living
in 1969. The purpose of the 1982 follow-up was to locate the original participants,
determine vital status, and obtain information about the health status of the participants
who were still alive, and cause of death of participants who had died between 1969 and 1982.
All individuals contacted were asked to participate in the proposed 25-year follow-up
physical examination. At that time in 1983 there were 2,534 surviving subjects. All data
gathered by the 1982 Mortality Follow-up were used in the 25-year follow-up.
DESIGN NARRATIVE:
The follow-up evaluated the power of cardiovascular disease risk factors, as measured in
1960, to predict coronary heart disease morbidity and mortality over 25 years and to predict
stroke. It also evaluated the power of changes in cardiovascular disease risk factors as
observed across the seven repeat exams from 1960 to 1969, to predict long-term morbidity and
mortality and provided the basis for a potential future follow-up of an aging cohort.
The 25-year follow-up extended the existing database by adding current risk factor status
and cardiovascular disease morbidity data collected by physical examinations and personal
interviews. The new data included physical, physiological, and biochemical variables, health
behavior, medical and family history, and Type A behavior. Existing mortality records were
updated and used to determine cause of death and, where possible, the extent of
cardiovascular pathology.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|